Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Point of Care Coagulation Testing Devices Market Growth, Size, Share: By Device Type: Anticoagulation Monitoring Devices, Platelet Function Monitoring Devices, Viscoelastic Coagulation Monitoring Devices, Others; By End Use: Hospitals and Clinics, Homecare, Others; Regional Analysis; Competitive Landscape; 2018-2028

Gloobal Point of Care Coagulation Testing Devices Market Outlook

The global point of care coagulation testing devices market is expected to grow at a CAGR of 6.10% between 2023 and 2028. Key market drivers are increasing prevalence of bleeding disorders, growing geriatric population, and increasing need for coagulation diagnostics.

 

Key Trends in the Market

Point of care coagulation testing devices are machines that help immediately examine the coagulation status of patients in real-time. Some of the point of care coagulation testing devices include blood gas analysis, viscoelastic coagulation tests, platelet function tests, and various other coagulometers. These help in assessing homeostasis and act as an important tool for individualised, factor-based, and goal-directed substitution therapy. Advantages of this testing are rapid medical decisions, fast turn around times, requirement of small specimen volumes, and avoidance of sample transport and identification issues.

 

  • There is increasing demand for vital function monitoring viscoelastic device Thromboelastography (TEG), owing to its ability to detect pulmonary embolism or venous thromboembolism, fuelling the market growth.
  • Demand for homecare coagulation testing is on the rise, to monitor condition status of patients while away from the hospital, without requiring patients to spend exorbitant amounts on unnecessary hospital stays. This is particularly useful for diseases such as VWD and haemophilia.
  • Growing investments by the companies for the development of easy to operate and advanced point of care coagulation testing devices is also a major trend contributing to the growth of the point of care coagulation testing devices market.

 

Market Analysis

Based on device type, the market can be divided into anticoagulation monitoring devices, platelet function monitoring devices, and viscoelastic coagulation monitoring devices, among others. Viscoelastic coagulation monitoring devices are further classified by type into thromboelastography (TEG) and rotational thromboelastometry (ROTEM). On the basis of end use, the market is segmented into hospitals and clinics, and homecare, among others. By region, the market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

 

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global point of care coagulation testing devices market covering their competitive landscape and latest developments like mergers, acquisitions, investments, and expansion plans.

 

  • Medtronic, plc
  • Abbott Laboratories
  • Siemens Healthineers AG
  • F. Hoffmann-La Roche Ltd
  • HemoSonics, LLC
  • Others

 

Market Share by Device Type

Viscoelastic coagulation monitoring devices been dominating the market and are expected to hold a larger share in the point of care coagulation testing devices market. This is due to the proven clinical efficiency of these devices in providing information on blood clots in every phase of coagulation leading to a successful haemostasis.

 

Meanwhile, due to the ability of anticoagulation monitoring devices to provide rapid as well as accurate results, they accounted for a large share in the market. They are widely adopted by healthcare facilities owing to their lower cost compared to other devices and high efficacy levels.

 

Market Share by End Use

Hospitals and clinics hold a larger share of the market for point of care coagulation testing devices. This is due to the higher rates of adoption of cutting-edge technology in these settings in comparison to homecare, and the presence of experienced medical professionals and technicians to use the point of care coagulation testing devices. The rising number of hospitalisations and patients with chronic diseases and chronic bleeding disorders are also increased in the demand for point of care coagulation testing in hospitals and clinics.

 

However, rising awareness among the general population regarding monitoring of bleeding disorders from at home has increased the demand and use of homecare point of care coagulation testing devices. As point of care coagulation testing devices become more user-friendly and affordable, homecare use of these devices is expected to grow in the forecast period.

 

Competitive Landscape

Medtronic, plc is an American medical device company that is known for producing therapies as well as medical devices, including revolutionary cardiac devices. Some of its products include diabetes insulin pumps and pacemakers that are battery powered and miniature. It has its headquarter in Dublin, Ireland and was founded in 1949.

 

Abbott Laboratories was established in 1888 and is headquartered in Illinois, United States. It is a healthcare company that designs and manufactures medical devices, among other healthcare products. It is known widely for its range of products such as diagnostic tools, diabetes and vascular devices, branded generic science-based nutritional products, and pharmaceuticals.

 

HemoSonics, LLC was founded in 2004 and is based in Virginia, United States. It is an in vitro diagnostics company that manufactures medical equipment and is majorly involved in the exploration of haemostasis and thrombosis. It also deals with cardiac surgery, patient blood management, cardiothoracic surgery, and orthopaedic surgery, among other medical issues.

 

Other market players include Siemens Healthineers AG, and F. Hoffmann-La Roche Ltd., among others.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Device Type
  • End Use
  • Region
Breakup by Device Type
  • Anticoagulation Monitoring Devices
  • Platelet Function Monitoring Devices
  • Viscoelastic Coagulation Monitoring Devices
    • Thromboelastography (TEG)
    • Rotational Thromboelastometry (ROTEM)
  • Others
Breakup by End Use
  • Hospitals and Clinics
  • Homecare
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Medtronic, plc
  • Abbott Laboratories
  • Siemens Healthineers AG
  • F. Hoffmann-La Roche Ltd
  • HemoSonics, LLC
  • Others

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Point of Care Coagulation Testing Devices Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Point of Care Coagulation Testing Devices Historical Market (2018-2022) 
    8.3    Global Point of Care Coagulation Testing Devices Market Forecast (2023-2028)
    8.4    Global Point of Care Coagulation Testing Devices Market by Device Type
        8.4.1    Anticoagulation Monitoring Devices
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
        8.4.2    Platelet Function Monitoring Devices
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
        8.4.3    Viscoelastic Coagulation Monitoring Devices
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2018-2022)
            8.4.3.3    Forecast Trend (2023-2028)
            8.4.3.4    Breakup by Type
                8.4.3.4.1    Thromboelastography (TEG)
                8.4.3.4.2    Rotational Thromboelastometry (ROTEM)
        8.4.4    Others 
    8.5    Global Point of Care Coagulation Testing Devices Market by End Use
        8.5.1    Hospitals and Clinics
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Homecare
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
        8.5.3    Others
    8.6    Global Point of Care Coagulation Testing Devices Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2018-2022)
        9.1.2    Forecast Trend (2023-2028)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2018-2022)
        9.2.2    Forecast Trend (2023-2028)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2018-2022)
        9.3.2    Forecast Trend (2023-2028)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2018-2022)
        9.4.2    Forecast Trend (2023-2028)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2018-2022)
        9.5.2    Forecast Trend (2023-2028)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Medtronic, plc 
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Abbott Laboratories
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Siemens Healthineers AG 
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    F. Hoffmann-La Roche Ltd 
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    HemoSonics, LLC
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Others
12    Industry Events and Developments

 

List of Key Figures and Tables

1.    Global Point of Care Coagulation Testing Devices Market: Key Industry Highlights, 2018 and 2028
2.    Global Point of Care Coagulation Testing Devices Historical Market: Breakup by Device Type (USD Million), 2018-2022
3.    Global Point of Care Coagulation Testing Devices Market Forecast: Breakup by Device Type (USD Million), 2023-2028
4.    Global Point of Care Coagulation Testing Devices Historical Market: Breakup by End Use (USD Million), 2018-2022
5.    Global Point of Care Coagulation Testing Devices Market Forecast: Breakup by End Use (USD Million), 2023-2028
6.    Global Point of Care Coagulation Testing Devices Historical Market: Breakup by Region (USD Million), 2018-2022
7.    Global Point of Care Coagulation Testing Devices Market Forecast: Breakup by Region (USD Million), 2023-2028
8.    North America Point of Care Coagulation Testing Devices Historical Market: Breakup by Country (USD Million), 2018-2022
9.    North America Point of Care Coagulation Testing Devices Market Forecast: Breakup by Country (USD Million), 2023-2028
10.    Europe Point of Care Coagulation Testing Devices Historical Market: Breakup by Country (USD Million), 2018-2022
11.    Europe Point of Care Coagulation Testing Devices Market Forecast: Breakup by Country (USD Million), 2023-2028
12.    Asia Pacific Point of Care Coagulation Testing Devices Historical Market: Breakup by Country (USD Million), 2018-2022
13.    Asia Pacific Point of Care Coagulation Testing Devices Market Forecast: Breakup by Country (USD Million), 2023-2028
14.    Latin America Point of Care Coagulation Testing Devices Historical Market: Breakup by Country (USD Million), 2018-2022
15.    Latin America Point of Care Coagulation Testing Devices Market Forecast: Breakup by Country (USD Million), 2023-2028
16.    Middle East and Africa Point of Care Coagulation Testing Devices Historical Market: Breakup by Country (USD Million), 2018-2022
17.    Middle East and Africa Point of Care Coagulation Testing Devices Market Forecast: Breakup by Country (USD Million), 2023-2028
18.    Global Point of Care Coagulation Testing Devices Market Structure

Key Questions Answered in the Report

The market is expected to grow at a CAGR of 6.10% between 2022 and 2027.

The major market drivers include growing prevalence of bleeding disorders, increasing geriatric population, and need for coagulation diagnostics.

The key trends of the market are growing popularity of Thromboelastography (TEG), increasing demand for homecare testing, and rising investments for the development of advanced devices.

Key market players include Medtronic, plc, Abbott Laboratories, Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., and HemoSonics, LLC, among others.

Point of care coagulation testing devices are machines that help immediately examine the coagulation status of patients in real-time.

Point of care coagulation testing devices help in assessing homeostasis and act as an important tool for individualised, factor-based, and goal-directed substitution therapy.

The global point of care coagulation testing devices market is segmented based on device type, end use, and region.

Advantages of point of care coagulation testing are support for rapid medical decisions, fast turn-around times, requirement of small specimen volumes, and avoidance of sample transport and identification issues.

Purchase Full Report

Mini Report

$ 2199     $1799
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER